Skip to main content

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

Literatur

  • Delange F (1998) Risks and benefits of iodine supplementation. Lancet 351: 923–924

    CAS  PubMed  Google Scholar 

  • Derwahl M, Studer H (2000) Multinodular goitre: „much more to it than simply iodine deficiency“. Baillieres Best Pract Res Clin Endocrinol Metab 14: 577–600

    Article  CAS  PubMed  Google Scholar 

  • Feldkamp J, Seppel T, Becker A, Klisch A, Schlaghecke R, Goretzki PE, Roher HD (1997) Iodide or L-thyroxine to prevent recurrent goiter in an iodine-deficient area: prospective sonographic study. World J Surg 21: 10–14

    Article  CAS  PubMed  Google Scholar 

  • Gärtner R, Dugrillon A (1998) Vom Jodmangel zur Struma. Internist 39: 566–573

    PubMed  Google Scholar 

  • Hegedus L, Nygaard B, Hansen JM (1999) Is routine thyroxine treatment to hinder postoperative recurrence of nontoxic goiter justified? J Clin Endocrinol Metab 84: 756–760

    Article  CAS  PubMed  Google Scholar 

  • Hintze G, Emrich D, Köbberling J (1989) Treatment of endemic goitre due to iodine deficiency with iodine, levothyroxine or both: results of a multicentre trial. Eur J Clin Invest 19: 527–534

    CAS  PubMed  Google Scholar 

  • Kahaly G, Dienes HP, Beyer J, Hommel G (1997) Randomized, double blind, placebo-controlled trial of low dose iodide in endemic goiter. J Clin Endocrinol Metab 82: 4049–4053

    Article  CAS  PubMed  Google Scholar 

  • Leitlinien der Deutschen Gesellschaft für Chirurgie (1998) Therapie der benignen Struma. AWMF online, www.uni-duesseldorf.de/AWMF

    Google Scholar 

  • Papini E, Petrucci L, Guglielmi R et al. (1998) Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules. J Clin Endocrinol Metab 83: 780–783

    Article  CAS  PubMed  Google Scholar 

  • Quadbeck B, Pruellage J, Roggenbuck U et al. (2002) Long-term follow-up of thyroid nodule growth. Exp Clin Endocrinol Diabetes 110: 348–354

    Article  CAS  PubMed  Google Scholar 

Literatur

  • Abraham P, Avenell A, Watson WA et al. (2003) Antithyroid drug regimen for treating Graves’ hyperthyroidism. Cochrane Database Syst Rev CD003420

    Google Scholar 

  • Belfiore A, Russo D, Vigneri R, Filetti S (2001) Graves’ disease, thyroid nodules and thyroid cancer. Clin Endocrinol (Oxf) 55: 711–718

    Article  CAS  Google Scholar 

  • Benker G, Reinwein D, Kahaly G, Tegler L, Alexander WD, Fassbinder J, Hirche H (1998) Is there a methimazole dose effect on remission rate in Graves’ disease? Results from a long-term prospective study. The European Multicentre Trial Group of the Treatment of Hyperthyroidism with Antithyroid Drugs. Clin Endocrinol (Oxf) 49: 451–457

    Article  CAS  Google Scholar 

  • Feldt-Rasmussen U, Schleusener H, Carayon P (1994) Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves’ disease. J Clin Endocrinol Metab 78: 98–102

    Article  CAS  PubMed  Google Scholar 

  • Hoermann R, Quadbeck B, Roggenbuck U et al. (2002) Relapse of Graves’ disease after successful outcome of antithyroid drug therapy: results of a prospective randomized study on the use of levothyroxine. Thyroid 12: 1119–1128

    Article  CAS  PubMed  Google Scholar 

  • Horacek J, Franklyn JA (2003) Radioiodine treatment of Graves’ hyperthyroidism. J Clin Endocrinol Metab 88: 6113

    Article  CAS  PubMed  Google Scholar 

  • Leitlinien der Deutschen Gesellschaft für Nuklearmedizin (1999) Radiojodtherapie gutartiger Schilddrüsenkrankheiten. AWMF online, www.uniduesseldorf.de/AWMF

    Google Scholar 

  • Mandel SJ, Cooper DS (2001) The use of antithyroid drugs in pregnancy and lactation. J Clin Endocrinol Metab 86: 2354–2359

    Article  CAS  PubMed  Google Scholar 

  • Nedrebo BG, Holm PI, Uhlving S et al. (2002) Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with Graves’ disease. Eur J Endocrinol 147: 583–589

    Article  CAS  PubMed  Google Scholar 

  • Palit TK, Miller CC 3rd, Miltenburg DM (2000) The efficacy of thyroidectomy for Graves’ disease: A meta-analysis. J Surg Res 90: 161–165

    Article  CAS  PubMed  Google Scholar 

  • Pfeilschifter J, Ziegler R (1997) Suppression of serum thyrotropin with thyroxine in patients with Graves’ disease: effects on recurrence of hyperthyroidism and thyroid volume. Eur J Endocrinol 136: 81–86.

    CAS  PubMed  Google Scholar 

  • Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM (1998) The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr Rev 19: 673–716

    Article  CAS  PubMed  Google Scholar 

  • Reinwein D, Benker G, Lazarus JH, Alexander WD (1993) A prospective randomized trial of antithyroid drug dose in Graves’ disease therapy. European Multicenter Study Group on Antithyroid Drug Treatment. J Clin Endocrinol Metab 76: 1516–1521

    Article  CAS  PubMed  Google Scholar 

  • Spitzweg C, Rossmuller B, Heufelder AE (1998) Radioiodine therapy and Graves’ ophthalmopathy. Thyroid 8: 1193

    CAS  PubMed  Google Scholar 

  • Vestergaard P (2002) Smoking and thyroid disorders — a meta-analysis. Eur J Endocrinol 146: 153–161

    CAS  PubMed  Google Scholar 

  • Weetman AP (2000) Graves’ disease. N Engl J Med 343: 1236–1248

    Article  CAS  PubMed  Google Scholar 

  • Witte J, Goretzki PE, Dotzenrath C, Simon D, Felis P, Neubauer M, Roher HD (2000) Surgery for Graves’ disease: total versus subtotal thyroidectomy — results of a prospective randomized trial. World J Surg 24: 1303–1311

    Article  CAS  PubMed  Google Scholar 

Literatur

  • Bartalena L, Marcocci C, Pinchera A (2002) Graves’ ophthalmopathy: a preventable disease? Eur J Endocrinol 146: 457–461

    Article  CAS  PubMed  Google Scholar 

  • Bartalena L, Marcocci C, Tanda ML et al. (1998) Cigarette smoking and treatment outcomes in Graves ophthalmopathy. Ann Intern Med 129: 632–635

    CAS  PubMed  Google Scholar 

  • Gorman CA, Garrity JA, Fatourechi V et al. (2001) A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves’ ophthalmopathy. Ophthalmology 108: 1523–1534

    Article  CAS  PubMed  Google Scholar 

  • Heufelder AE (2000) Pathogenesis of ophthalmopathy in autoimmune thyroid disease. Rev Endocr Metab Disord 1: 87–95

    Article  CAS  PubMed  Google Scholar 

  • Kahaly GJ, Rosler HP, Pitz S, Hommel G (2000) Low-versus high-dose radiotherapy for Graves’ ophthalmopathy: a randomized, single blind trial. J Clin Endocrinol Metab 85: 102–108

    Article  CAS  PubMed  Google Scholar 

  • Krassas GE, Heufelder AE (2001) Immunosuppressive therapy in patients with thyroid eye disease: an overview of current concepts. Eur J Endocrinol 144: 311–318

    Article  CAS  PubMed  Google Scholar 

  • Marcocci C, Bartalena L, Tanda ML et al. (2000) Radiotherapy for Graves’ orbitopathy: randomised placebo-controlled study. Lancet 355: 1505–1509

    Google Scholar 

  • Prummel MF, Mourits MP, Blank L, Berghout A, Koornneef L, Wiersinga WM (1993) Randomized double-blind trial of prednisone versus radiotherapy in Graves’ ophthalmopathy. Lancet 342: 949–954

    Article  CAS  PubMed  Google Scholar 

  • Prummel MF, Terwee CB, Gerding MN et al. (2004) A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves’ ophthalmopathy. J Clin Endocrinol Metab 89: 15–20

    Article  CAS  PubMed  Google Scholar 

Literatur

  • Corvilain B, Van Sande J, Dumont JE, Bourdoux P, Ermans AM (1998) Autonomy in endemic goiter. Thyroid 8: 107–113

    CAS  PubMed  Google Scholar 

  • Derwahl M, Studer H (2000) Multinodular goitre: „much more to it than simply iodine deficiency“. Baillieres Best Pract Res Clin Endocrinol Metab 14: 577–600

    Article  CAS  PubMed  Google Scholar 

  • Emrich D (1999) Jodmangelstruma mit funktioneller Autonomie. Diagnostische und therapeutische Indikationen. Nuklearmedizin 38: 3–5

    CAS  PubMed  Google Scholar 

  • Krohn K, Paschke R (2001) Clinical review 133: Progress in understanding the etiology of thyroid autonomy. J Clin Endocrinol Metab 86: 3336–3345

    Article  CAS  PubMed  Google Scholar 

  • Leitlinien der Deutschen Gesellschaft für Nuklearmedizin (1999) Radiojodtherapie gutartiger Schilddrüsenkrankheiten. AWMF online, www.uni-duesseldorf.de/AWMF.

    Google Scholar 

  • Papini E, Panunzi C, Pacella CM, Bizzarri G, Fabbrini R, Petrucci L, Pisicchio G, Nardi F (1993) Percutaneous ultrasound-guided ethanol injection: a new treatment of toxic autonomously functioning thyroid nodules? J Clin Endocrinol Metab 76: 411–416

    Article  CAS  PubMed  Google Scholar 

  • Rendl J, Saller B (2001) Schilddrüse und Röntgenkontrastmittel — Pathophysiologie, Häufigkeit und medikamentöse Prophylaxe der iodinduzierten Hyperthyreose. Deutsches Ärzteblatt 98: 316–320

    Google Scholar 

  • Roti E, Uberti ED (2001) Iodine excess and hyperthyroidism. Thyroid 11: 493–500

    Article  CAS  PubMed  Google Scholar 

  • Sandrock D, Olbricht T, Emrich D, Benker G, Reinwein D (1993) Long-term follow-up in patients with autonomous thyroid adenoma. Acta Endocrinol (Copenh) 128: 51–55

    CAS  Google Scholar 

  • Schumm-Draeger PM (1998) Ultrasound-guided percutaneous ethanol injection in the treatment of autonomous thyroid nodules — a review. Exp Clin Endocrinol Diabetes 106: S59–62

    CAS  PubMed  Google Scholar 

  • Toft AD (2001) Clinical practice. Subclinical hyperthyroidism. N Engl J Med 345: 512–516

    Article  CAS  PubMed  Google Scholar 

  • Zingrillo M, Torlontano M, Ghiggi MR, Frusciante V, Varraso A, Liuzzi A, Trischitta V (2000) Radioiodine and percutaneous ethanol injection in the treatment of large toxic thyroid nodule: a long-term study. Thyroid 10: 985–989

    CAS  PubMed  Google Scholar 

Literatur

  • Dayan CM, Daniels GH (1996) Chronic autoimmune thyroiditis. N Engl J Med 335: 99–107

    Article  CAS  PubMed  Google Scholar 

  • Fatourechi V (2001) Subclinical thyroid disease. Mayo Clin Proc 76: 413–416; quiz 416–417

    CAS  PubMed  Google Scholar 

  • Koh LK, Greenspan FS, Yeo PP (1997) Interferon-alpha induced thyroid dysfunction: three clinical presentations and a review of the literature. Thyroid 7: 891–896

    CAS  PubMed  Google Scholar 

  • Martino E, Bartalena L, Bogazzi F, Braverman LE (2001) The effects of amiodarone on the thyroid. Endocr Rev 22: 240–254

    Article  CAS  PubMed  Google Scholar 

  • Muller AF, Drexhage HA, Berghout A (2002) Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care. Endocr Rev 22: 605–630

    Google Scholar 

  • Roberts CG, Ladenson PW (2004) Hypothyroidism. Lancet 363: 793–803

    Article  CAS  PubMed  Google Scholar 

  • Roti E, Uberti E (2002) Post-partum thyroiditis — a clinical update. Eur J Endocrinol 146: 275–279

    Article  CAS  PubMed  Google Scholar 

  • Schumm-Draeger PM (1998) Thyreoiditis. Formen, Diagnostik, Therapie. Internist (Berl) 39: 594–598

    CAS  Google Scholar 

  • Toft AD (1994) Thyroxine therapy. N Engl J Med 331: 174–180

    Article  CAS  PubMed  Google Scholar 

  • Walfish PG (1997) Thyroiditis. Curr Ther Endocrinol Metab 6: 117–122

    CAS  PubMed  Google Scholar 

  • Vanderpump MP, Tunbridge WM, French JM et al. (1995) The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 43: 55–68

    CAS  Google Scholar 

Literatur

  • Brandi ML, Gagel RF, Angeli A et al. (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86: 5658–5671

    Article  CAS  PubMed  Google Scholar 

  • Gimm O, Sutter T, Dralle H (2001) Diagnosis and therapy of sporadic and familial medullary thyroid carcinoma. J Cancer Res Clin Oncol 127: 156–165

    Article  CAS  PubMed  Google Scholar 

  • Giuffrida D, Gharib H (2000) Anaplastic thyroid carcinoma: current diagnosis and treatment. Ann Oncol 11: 1083–1089

    CAS  PubMed  Google Scholar 

  • Hoelzer S, Reiners C, Mann K, Bamberg M, Rothmund M, Dudeck J, Stewart AV, Hundahl SA (2000) Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. U.S. and German Thyroid Cancer Group. Cancer 89: 192–201

    Google Scholar 

  • Interdisziplinäre Leitlinie der Deutschen Krebsgesellschaft und der Deutschen Gesellschaft für Chirurgie (2002) Maligne Schilddrüsentumoren. AWMF online, www.uni-duesseldorf.de/AWMF

    Google Scholar 

  • Kebebew E, Clark OH (2000) Medullary thyroid cancer. Curr Treat Options Oncol 1: 359–367

    CAS  PubMed  Google Scholar 

  • Lawrence W Jr, Kaplan BJ (2002) Diagnosis and management of patients with thyroid nodules. J Surg Oncol 80: 157–170

    Article  PubMed  Google Scholar 

  • Mann K (2002) Diagnostik und Therapie differenzierter Schilddrüsenkarzinome. Internist (Berl) 43: 174–185

    CAS  Google Scholar 

  • Mazzaferri EL (1999) An overview of the management of papillary and follicular thyroid carcinoma. Thyroid 9: 421–427

    CAS  PubMed  Google Scholar 

  • Mazzaferri EL, Kloos RT (2000) Using recombinant human TSH in the management of well-differentiated thyroid cancer: current strategies and future directions. Thyroid 10: 767–778

    CAS  PubMed  Google Scholar 

  • Saller B (2001) Treatment with cytotoxic drugs. In: Biersack HJ, Grünwald F, Hrsg. Thyroid cancer. Springer, Berlin Heidelberg New York Tokyo, pp 139–151

    Google Scholar 

  • Schmid KW, Shen SY, Görges R et al. (2003) Tumoren der Schilldrüse. Pathologe 24: 357–372

    Article  CAS  PubMed  Google Scholar 

Literatur

  • Janssen OE (1998) Resistenz gegen Schilddrüsenhormone. Internist (Berl) 39: 613–618

    CAS  Google Scholar 

  • Weiss RE, Refetoff S (2000) Resistance to thyroid hormone. Rev Endocr Metab Disord 1: 97–108

    Article  CAS  PubMed  Google Scholar 

Literatur

  • Betterle C, Dal Pra C, Mantero F, Zanchetta R (2002) Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 23: 327–364

    Article  CAS  PubMed  Google Scholar 

Literatur

  • Reichmann I, Frilling A, Hörmann R, Krause U, Broelsch CE (2001) Frühoperation als Behandlungsmassnahme der thyreotoxischen Krise. Chirurg 72: 402–407

    CAS  PubMed  Google Scholar 

  • Ringel MD (2001) Management of hypothyroidism and hyperthyroidism in the intensive care unit. Crit Care Clin 17: 59–74

    Article  CAS  PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Heidelberg

About this chapter

Cite this chapter

Saller, B., Janssen, O.E. (2005). Schilddrüse. In: Schölmerich, J., et al. Medizinische Therapie 2005|2006. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27385-9_60

Download citation

  • DOI: https://doi.org/10.1007/3-540-27385-9_60

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-21226-3

  • Online ISBN: 978-3-540-27385-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics